Big Data & Cancer Research
Cancer researchers have the ability to collect more data on patients in clinical trials than ever before. Analyzing these “big data” sets could...
Read MoreWarmest Wishes
Wishing you and your loved ones a joyful holiday season and a Happy New Year! The Metastatic Trial Talk...
Read MoreTips for Reading Cancer News
Groundbreaking. Game-changing. Promising. These are just some of the words often seen in media coverage of new cancer treatments. But how does a reader or viewer...
Read MoreWhat Do Drug Names Mean?
Have you ever wondered: How did trastuzumab (Herceptin) get its name? Or why is the biosimilar for Herceptin called trastuzumab-anns (Kanjinti)? As the articles...
Read MoreGetting Through the Holidays While Living with MBC
With the holidays approaching, you are probably busier than usual. Holiday celebrations when you are living with cancer can be challenging. You may be managing...
Read MoreDiagnosing & Treatment of Bone Metastases
When breast cancer spreads, one of the first sites it often goes to is bone. The articles below discuss diagnosis and treatment of bone metastases. Bone...
Read MoreWhat is a Tumor Agnostic Therapy?
In May 2017, the U.S. Food and Drug Administration (FDA) approved the first tumor/tissue agnostic therapy. These drugs are approved for use for any tumor that has...
Read MoreTrue or False?
2% of breast cancer patients are diagnosed initially with stage IV metastatic disease. Answer: False Between 6-10% of breast cancer patients are diagnosed...
Read MoreExpanding Eligibility Criteria
Every clinical trial has a list of eligibility criteria. This list details who can take part in a particular study. These criteria are necessary because ruling...
Read MoreSEARCH OUR SITE
for past articles or specific information.